Official UK procurement notice
Provision of Urgent Award MSK Pain Management and Rheumatology on behalf of NHS Mid and South Essex ICB
Authority: NHS Mid and South Essex Integrated Care Board (NHS & healthcare)
What is being bought
Published requirement descriptionThe current re procurement of MSK Pain Management and Rheumatology Services has had unforeseen delays and there must not be a gap in service provision for the population which would impact patients by deteriorating their current conditions. The current contract with the incumbent expires on 31st October 2025 and as a consequence there is a requirement to award a short term contract whilst the procurement concludes. The new contract will be for a further 7 months with an option to extend for a further 5 months from 01st April 2025 to 31st March 2026.
CPV: Health services
The lotProcurement structure
single lot · no lot value publishedLot #1The current MSK Pain Management and Rheumatology Contract to provide the services to…Awarded
The current MSK Pain Management and Rheumatology Contract to provide the services to patients within NHS Mid and South Essex Integrated Care Board (Basildon and Brentwood and Thurrock) will expire on 31st October 2025. The Urgent Award to the existing provider is to ensure that there is continued provision of MSK Pain Management and Rheumatology Services to the registered population of NHS Mid and South Essex Integrated Care Board (Basildon and Brentwood and Thurrock) whilst the procurement in place to award a new contract is concluded. There is a requirement to award a new short term contract for 7 months, with an option to extend for a further 5 months 01st April 2025 - 31st March 2026.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 10 Mar 2025, 13:18 GMT
- Last source update
- 10 Mar 2025, 13:18 GMT
- Authority reference
ACE-0755-2024-MSE- FTS notice number
2025/S 000-008527- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04eafeFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
The current re procurement of MSK Pain Management and Rheumatology Services has had unforeseen delays and there must not be a gap in service provision for the population which would impact patients by deteriorating their current conditions. The current contract with the incumbent expires on 31st October 2025 and as a consequence there is a requirement to award a short term contract whilst the procurement concludes. The new contract will be for a further 7 months with an option to extend for a further 5 months from 01st April 2025 to 31st March 2026.
Publisher note: This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply in this award. The current re procurement of MSK Pain Management and Rheumatology Services has had unforeseen delays and there must not be a gap in service provision for the population which would impact patients by deteriorating their current conditions. The current contract with the incumbent expires on 31st October 2025 and as a consequence there is a requirement to award a short term contract whilst the procurement concludes. The new contract will be for a further 7 months with an option to extend for a further 5 months from 01st April 2025 to 31st March 2026. Decision makers are: NHS Mid and South Essex ICB Executive Team No conflicts of interest have been identified
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Connect Health LtdProvision of Urgent Award for MSK, Pain Management and Rheumatology Services | £3,147,575 † | — | Awarded |
Contracts
Provision of Urgent Award for MSK, Pain Management and Rheumatology Services · Connect Health Ltd
- Signed
- 5 Nov 2024
- Value
- £3,147,575
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The Royal Courts of JusticeReview body
Bidders & participating suppliers
1 commercial party on the notice- Connect Health LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.